Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cryoglobulinemic vasculitis.

Clodoveo Ferri1, Maria Teresa Mascia

  • 1Chair and Rheumatology Unit, Department of Internal Medicine, University of Modena e Reggio Emilia, Medical School, Modena, Italy. clferri@unimore.it

Current Opinion in Rheumatology
|December 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical profile of systemic sclerosis without a 'scleroderma pattern' at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of Rheumatology.

Journal of translational autoimmunity·2026
Same author

Rethinking nailfold capillaroscopy in SSc: proposal for a novel binary classification of capillary changes based on severity.

Rheumatology (Oxford, England)·2026
Same author

Cryoglobulinemia and Cryofibrinogenemia: Ten years of experience and diagnostic perspectives from a large laboratory-based cohort.

Clinical biochemistry·2026
Same author

Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.

RMD open·2026
Same author

HCV-related cryoglobulinemic vasculitis (mixed cryoglobulinemia syndrome) in the era of direct-acting antivirals: A 10-year experience from Italian tertiary referral centers.

Journal of autoimmunity·2026
Same author

Comment on: Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry: Reply.

Rheumatology (Oxford, England)·2026
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Hepatitis C virus (HCV) drives cryoglobulinemic vasculitis by stimulating the immune system, leading to autoantibodies and potential B-cell lymphomas. Treatment strategies for this condition are tailored to individual patient needs.

Area of Science:

  • Immunology
  • Virology
  • Rheumatology

Background:

  • Cryoglobulinemic vasculitis is a systemic vasculitis affecting small-medium vessels.
  • Hepatitis C virus (HCV) is implicated in over 80% of cases.
  • Understanding the interplay between HCV and the immune system is crucial.

Purpose of the Study:

  • To review recent advances in the etiopathogenesis, diagnosis, and treatment of cryoglobulinemic vasculitis.
  • To explore the role of HCV in the development of this condition.
  • To highlight the complex relationship between autoimmune and lymphoproliferative disorders.

Main Methods:

  • Literature review of recent studies on cryoglobulinemic vasculitis.
  • Analysis of the pathogenetic mechanisms involving HCV.

Related Experiment Videos

  • Examination of clinical presentations and diagnostic challenges.
  • Evaluation of current and emerging therapeutic strategies.

    • Main Results:

    • HCV chronic infection can lead to immune system stimulation, B-cell activation, and autoantibody production.
    • The interaction of HCV envelope protein E2 with CD81 receptor may promote B-cell survival and oncogene activation.
    • Cryoglobulinemic vasculitis can be associated with malignancies, particularly B-cell lymphomas.
    • Overlap with other conditions like Sjögren's syndrome and autoimmune hepatitis requires careful diagnosis.
    • Survival rates for cryoglobulinemic vasculitis patients are lower than the general population.

    Conclusions:

    • Cryoglobulinemic vasculitis serves as a model for studying virus-related autoimmune and lymphoproliferative disorders.
    • HCV is a primary driver, making etiological treatment essential.
    • Personalized therapeutic approaches combining antiviral, pathogenetic, and symptomatic treatments are necessary.